Under the terms of the deal, GIC, one of the world’s biggest institutional investors, and healthcare-focused private equity group Linden Capital Partners will buy out a minority stake owned by rival ...

The African Pharmaceutical Market is projected to grow at an impressive CAGR of 6-8% by 2029, driven by a booming population, ...

The head of the EU's pharmaceutical lobby has called for the creation of a life sciences-focused stock market in Europe, ...

A long-time Bayer employee with diverse financial experience is taking on a new challenge at the helm of the company's North ...

Torrent Pharma has acquired a majority stake in JB Chemicals at an equity valuation of Rs 25,689 crore from US-based ...

Torrent Pharmaceuticals is set to acquire a 46.39% controlling stake in JB Chemicals and Pharmaceuticals from KKR for ₹11,917 ...

Climate-Smart Farming Practices, Soil Health Enhancement, and Carbon Sequestration Drive 14.2% CAGR Growth Across Agricultural Sectors Worldwide REDDING, Calif., June 25, 2025 /PRNewswire/ ...

TEL AVIV, Israel, May 6, 2025 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for cardiometabolic diseases and GI ...

Bayer Aktiengesellschaft is currently sporting a Zacks Rank of #2 (Buy). Over the past 90 days, the Zacks Consensus Estimate for BAYRY's full-year earnings has moved 9.4% higher.

Bayer Cropscience Limited shares surged as much as 13% in today’s trade after the company posted a robust performance during the quarter ended March 2025. The counter touched an intraday high of ...

“2025 is a landmark launch year for Bayer Pharmaceuticals, and we are pulling out all stops to drive the power of our pipeline,” said Stefan Oelrich, Member of the Board of Management, Bayer ...